All News

I never fully understood how ingrained my children were in my soul until I had to give serious thought to the end of my own life, and I knew I didn't want to face it without them.

While celebrating Christmas this year, there was a moment that really surprised me. My youngest stepson said something about being sorry he wasn’t more help when I was going through cancer.

How we deal with our cancer may be a matter of perspective.

The Food and Drug Administration approved Cabometyx (cabozantinib) tablets for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with Nexavar (sorafenib).

The Food and Drug Administration (FDA) has granted the investigational BTK inhibitor zanubrutinib (BGB-3111) a breakthrough therapy designation for the treatment of adult patients with mantle cell lymphoma (MCL) who have previously received at least one prior therapy, according to BeiGene, the company manufacturing the agent.

People who have experienced high exposures to gasoline might be at an increased risk for kidney cancer, according to recent research.

Treatment side effects are typically manageable for patients with metastatic kidney cancer, but patients must have open communication with their health care team about them.

Certain groups of pediatric and adolescent patients are less likely to receive fertility preservation consultation, recent research says.

Limbs affected by lymphedema require specialized care, but during months where temperatures can be extreme, a little extra effort is necessary.

Recent research found that outpatient palliative care improved survival and quality of life in patients with advanced cancer.

Two-time cancer survivor suggests a careful approach when researching your own cancer.

As cancer once again robbed me of the chance to make the holiday memories I had hoped for, it took a kid eating frozen pizza on Christmas Eve to remind me what really mattered.

In conjunction with Cervical Cancer Awareness Month, recognized in the month of January, here are some fast facts about the disease.

Three ways this metastatic breast cancer patient has made research participation a part of her life.

A recent meta-analysis has found no noticeable difference in immunotherapy’s efficacy based on patient sex.

A former caregiver's ongoing journey.

Half of patients diagnosed with advanced non-small cell lung cancer were alive 6.8 years after diagnosis, according to new study findings.

Rather than revisiting the ghosts of cancer treatments past, I’m focused on using what I’ve learned in three years of active treatment and maintenance for incurable, metastatic cancer.

I often joke in training classes on aging that with every new candle on my birthday cake, a new medicine bottle shows up in my cabinet.

Breast cancer survivor shares the silver lining in her breast reconstruction fat-grafting experience.

Cancer survivorship is an important topic that patients and physicians must consider when planning their treatment.

The Raymond Foundation released the Cancer Caregiver Action Plan to help others with emotional support and information.

Winter can seem dreary sometimes, but there are benefits to the season, too.

In an interview with CURE, Filippo Milano, M.D., Ph.D., explains what cord blood transplantation is and why it is important for patients to learn more.

As we celebrate the holidays, wish lists are made for gifts. I have a wish list for cancer.

Next-generation sequencing and personalized approaches will continue to improve cancer outcomes. But there’s still much work to be done.

For young breast cancer survivors, the type of surgery they recieve to treat their disease can impact their quality of life, according to recent research.

Real resolutions to make 2019 feel like a year of finally putting away unachievable goals from the past.

The Food and Drug Administration (FDA) approved Sprycel (dasatinib) plus chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

An expert discusses the current landscape – as well as future prospects – for immunotherapy in lung cancer.